Ascend Capital’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-180,629
Closed -$2.81M 260
2017
Q3
$2.81M Buy
+180,629
New +$2.81M 0.11% 129